Silvi was founded in 2018 by Professor in Health Economic Evidence, Tove Holm-Larsen. The idea for Silvi stemmed from Holm-Larsen’s own research, and the need to conduct meta-analyses faster.
Originally, the ideas behind Silvi were a component of a larger project. In 2016, Professor Holm-Larsen founded the group “Evidensbaseret Medicin 2.0” in collaboration with researchers from Ghent University, Technical University of Denmark, University of Copenhagen, and other experts. The goal of EBM 2.0 was to answer the question:
Silvi has been privileged to established partnership and receive funding from both private investors and investment funds. We’re always interested in collaboration and partnership with new innovative, creative minds. Please reach out to us at firstname.lastname@example.org to talk about collaboration.